Advertisement

Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Person › Details

Britt Meelby Jensen (Zealand Pharma A/S (Nasdaq: ZEAL))

Meelby Jensen, Britt (Zealand Pharma 201508 CEO)

 

Organisation Organisation Zealand Pharma A/S (Nasdaq: ZEAL)
  Group Zealand Pharma (Group)
Products Product Lyxumia® (Adlyxin™)
  Product 2 LixiLan®
Document Source Zealand Pharma A/S. (8/28/15). "Press Release: Financial Results in Line with Expectations and Important Progress of the Pipeline". Copenhagen.
     

   
Record changed: 2018-02-20

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px


More documents for Britt Meelby Jensen


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81




» top